Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Nederlands Tijdschrift Voor Geneeskunde|July 12, 1997
[Hypothermia in patients with a high spinal cord lesion]J W Fijen, P O Mulder, J G ZijlstraThe Netherlands Journal of Medicine|August 1, 1991
Tumour necrosis factor (cachectin) and other cytokines in septic shock: a review of the literatureA S Dofferhoff, E Vellenga, P C Limburg, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1988
Renal dysfunction following high-dose carboplatin treatmentP O Mulder, D T Sleijfer, E G de Vries, et al.The Netherlands Journal of Medicine|July 1, 1996
Amanita phalloides, a potentially lethal mushroom: its clinical presentation and therapeutic optionsE H Serné, A W Toorians, J A Gietema, et al.Intensive Care Medicine|August 1, 1997
Pharmacokinetics of piperacillin and tazobactam in critically ill patients with renal failure, treated with continuous veno-venous hemofiltration (CVVH)T S van der Werf, P O Mulder, J G Zijlstra, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1988
Absence of relation between nutritional parameters and renal function in non-seminomatous testicular cancer patientsJ A Gietema, E G de Vries, S Meijer, et al.Cancer Research|August 15, 1989
High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumorsP O Mulder, D T Sleijfer, P H Willemse, et al.British Journal of Cancer|March 1, 1990
Pharmacokinetics of carboplatin at a dose of 750 mg m-2 divided over three consecutive daysP O Mulder, E G de Vries, D R Uges, et al.Scandinavian Journal of Infectious Diseases|January 1, 1991
Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo studyA S Dofferhoff, J H Nijland, H G de Vries-Hospers, et al.Circulatory Shock|June 1, 1994
Lactate monitoring with subcutaneous microdialysis in patients with shock: a pilot studyJ de Boer, H Potthoff, P O Mulder, et al.Pageof 3